Sr. Srinivasan et al., Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study, METABOLISM, 50(6), 2001, pp. 696-702
To elucidate to what extent apolipoprotein (apo) E polymorphism modulates o
besity-induced dyslipidemias during young adulthood, longitudinal data on 7
59 individuals (72% white/28% black; initial and follow-up mean age, 25.9 a
nd 32.7 years) were examined. Among both races and the total sample, the ap
o E2 group (with E2/2 or E2/3 phenotype) had significantly lower and the ap
o E4 (with E4/4 or E3/4 phenotype) group higher low-density lipoprotein (LD
L) cholesterol than the apo E3 (with E3/3 phenotype) group at both examinat
ions. In addition, the apo E2 group displayed higher high-density lipoprote
in (HDL) cholesterol in the total sample. No allele-specific effect was not
ed for the longitudinal changes (Delta). An increase in Delta adiposity, me
asured as Delta body mass index (BMI), was accompanied by higher increase i
n Delta LDL cholesterol in the e4 carriers than the e2 carriers among the w
hites (P < .05) and the total sample (P < .01); an increase in Delta trigly
cerides end decrease in Delta HDL cholesterol in the e2 carriers than the e
4 carriers among all the groups (P < .05 to .001). Among the apo E phenotyp
e groups, the incidence of high (>75th percentile specific for race and sex
) LDL cholesterol at follow-up was in the order E4 > E3 > E2 both in the ob
ese (BMI > 30; P for trend = .033) and the nonobese (BMI < 25; P for trend
= .035) groups. Although the increase of low (<25th percentile specific for
race and sex) HDL cholesterol or high triglycerides showed no apo E phenot
ype-specific trend, the incidence of high triglycerides without high LDL ch
olesterol was in the order E2 > E3 > E4 only in the obese group (P for tren
d = .025). The prevalence trend for dyslipidemias at follow-up among the pe
rsistently obese and nonobese groups also gave similar results. Thus, apo E
gene locus influences not only the levels of certain lipoprotein variables
during young adulthood, but also modulates the association between obesity
and dyslipidemias. Copyright (C) 2001 by W.B. Saunders Company.